O.K., gotta throw this in, Post 1797, my guess was Dec. 18.
Things are looking so good for Sunrise right now. The New Orleans convention was a smashing sucess, Doctors understand the potentiol not only for the stock but for their own revenue generation. 12 million raised, now over 20 million in the bank, enough to back a powerful launch (Sept 13 my guess) . BTW, that private placement stock is restricted and won't affect the flaot for quite some time.My associate who attended the New Orleans convention revealed that Doctors were very excited by the lower cost of the lasers and the speed , precesion and 3 second time needed to perform the operation. He threw some numbers around, and they are preety exciting . Alot of doctors want the lasers on day 1 after approval. Let's take a look at some theoretical #'s. In the first year of sales a goal of 500 lasers to 500 doctors.
500 X $70,000 (Sunrise profit f/ laser sale, approx.)= $35,000,000
500 do 300 procedures in 1 year, conservative average 150,000
That is 300,000 eyes x $150 per eye fee to Sunrise= $45,000,000
Total profit for Sunrise 80 million dollars over $2 a share in earnings
These numbers he gave me don't seem unrealistic, but even 100 lasers sold gives us 20 million in profits.
He also pointed out that the marker is HUGE for hyperopia. 200 million in US and Europe, he thinks bigger then LASX's myopic market. All of the boomers with their glasses to read the paper. He said that the Doctors he met that were involved big with Sunrise were
extreamely well respected, powerful, wealthy guys. They own a ton of stock, which I like because it is in secure, stable , long term hands. It
was interesting to get the Doctors perspective. If 1 clinic can do 1000
patient procedures, let's look at the numbers again.
1000 procedures
2000 eyes
2000 x $2000 per eye = $4,000,000
put the clinics margins at 30% and the clinic makes 1.3 million. That is why the doctors are so excited. That is why they were so eager to get into the private placement and why they want the lasers on day 1 after approval. Many of the doctors involved run much bigger operations already doing VISX stuff. It is very difficult to treat Hyperopia with the present VISX laser, risky, painful, etc. Sunrise's procedure is easy for the Doctors to learn. The lasers are state of the art and really wowed the audience.
About the stock? Well, biotechs have been heating up again, and the NASD listing along with the PMA is attracting alot of instititutional
money. I could go on, I'll save some for later.
|
